Jun 16, 2022 / 04:20PM GMT
Ziyi Chen - Goldman Sachs Group, Inc., Research Division - Equity Analyst
Great. Thank you for joining this session with Zai Lab. This is China healthcare analyst Ziyi Chen. And today's session is with Zai Lab CFO, Billy Cho. Thank you for joining.
Questions and Answers:
Ziyi Chen - Goldman Sachs Group, Inc., Research Division - Equity AnalystBilly, let's get started with the Shanghai lockdown. So how that has been impacting your operations? Is everyone back to the office yet?
Ki Chul Cho - Zai Lab Limited - CFO
Yes. Thanks, Ziyi, and good morning, everyone. Yes, pretty much since June 1, so a little over 2 weeks now, everyone is back in the office and functioning normally. As some of you may be seeing in media, what they did was -- Shanghai to be specific -- really increased the testing capacity so that if there's any super-spreader events, they can quickly mobilize and -- so you may see an increase in the cadence of testing. But that's going to result in, hopefully, no more systematic lockdowns.
So
Trustpilot
